<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-042649</identifier>
<setSpec>1698-6946</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Epidermoid carcinoma of the lip: An immunohistochemical study</dc:title>
<dc:description xml:lang="en">Objectives: To determine the expression of the c-erb-B2, p53,bcl-2, Ki67 and CD44varV6 proteins, and to establish theirprognostic value in epidermoid carcinoma of the lip.Study design: Immunohistochemical study of the c-erb-B2,p53, bcl-2, Ki67 and CD44varV6 proteins in 79 epidermoidcarcinomas of the lip, diagnosed and treated over a period of 20years. The data obtained were subjected to uni- and multi-variatestatistical analyses.Results: Immunostaining was positive in 75% of cases for c-erb-B2 protein, in 70.6% for p53 protein, in 3.8% for bcl-2 proteinand in 89.9% for adhesion molecule CD44varV6. Ki67 proteinexpression varied between a minimum of 0% and a maximum of6.29%. Most immunohistochemical factors analyzed presentedno prognostic value for epidermoid carcinoma of the lip. Onlythose patients affected by this type of tumor that expressed theadhesion molecule CD44varV6 were significantly associatedwith a greater survival calculated by means of Kaplan-Meieranalysis.Conclusions: The immunohistochemical techniques analyzedfor the anatomicopathological study of epidermoid carcinomaof the lip should not routinely be used due to their high cost andlow utility in daily clinical practice</dc:description>
<dc:creator>García-Montesinos Perea, Belén</dc:creator>
<dc:creator>Saiz Bustillo, Ramón</dc:creator>
<dc:creator>Val Bernal, José Fernando</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivos: Determinar la sobreexpresión de las proteínas cerb-B2, p53, bcl-2, Ki67 y CD44varV6 y establecer su valorpronóstico en el carcinoma epidermoide de labio.Diseño del estudio: Estudio inmunohistoquímico de las proteínasp53, c-erb-B2, bcl-2, ki67 y CD44varV6 en 79 carcinomasepidermoides de labio diagnosticados y tratados a lo largo deun periodo de 20 años. Los datos obtenidos fueron sometidosa análisis estadístico uni y multivariante.Resultados: La inmunotinción fue positiva en el 75% de los casospara la proteína c-erb-B2, en el 70,6% para la proteína p 53, enel 3,8% para la proteína bcl-2 y en el 89,9% para la molécula deadhesión cd44varV6. La expresión proteica de ki67 osciló entreun mínimo de 0% y un máximo de 6,29%. Los factores inmunohistoquímicosanalizados no presentaron valor pronóstico enel carcinoma epidermoide de labio, y solamente los pacientesafectados por este tipo de tumores que expresaban la moléculade adhesión CD44varV6 se asociaron de forma significativa conuna mayor supervivencia mediante el análisis de Kaplan-Meier.Conclusiones: Las técnicas inmunohistoquímicas analizadaspara el estudio anatomopatológico del carcinoma epidermoidede labio no deberían realizarse rutinariamente, dado su mayorcoste y su menor utilidad en la práctica clínica diaria</dc:description>
<dc:source>Med. oral patol. oral cir. bucal (Internet);10(5): 454-461, nov.-dic. 2005. ilus, graf</dc:source>
<dc:identifier>ibc-042649</dc:identifier>
<dc:title xml:lang="es">Estudio inmunohistoquímico del carcinoma epidermoide de labio</dc:title>
<dc:subject>^d24890</dc:subject>
<dc:subject>^d30313</dc:subject>
<dc:subject>^d24373^s22002</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d29089^s22002</dc:subject>
<dc:subject>^d33060^s22002</dc:subject>
<dc:subject>^d33061^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24842</dc:subject>
<dc:subject>^d32845^s22002</dc:subject>
<dc:subject>^d23259^s22002</dc:subject>
<dc:subject>^d32062^s22002</dc:subject>
<dc:subject>^d9556^s22002</dc:subject>
<dc:subject>^d22544^s29165</dc:subject>
<dc:subject>^d22921</dc:subject>
<dc:subject>^d36227^s22002</dc:subject>
<dc:subject>^d2337^s29165</dc:subject>
<dc:type>article</dc:type>
<dc:date>200512</dc:date>
</metadata>
</record>
</ibecs-document>
